Evaluation vitro bromodeoxyuridine labeling breast carcinomas use commercial kit prognostic significance S-phase fraction analyses breast carcinomas several investigators Cell Proliferation Kit Amersham Corporation Arlington Heights IL vitro bromodeoxyuridine BRDU cell cycle kinetics flow cytometer radioisotopes simplifies assay clinical-based laboratory standardized reagents methods study data use comparable S-phase data use thymidine labeling BRDU methods breast carcinomas Primary infiltrating ductal carcinomas primary lobular carcinomas mean median BRDU labeling range Benign lesions BRDU uptake Estrogen receptor ER progesterone receptor PR status BRDU S-phase fractions ER- PR-negative tumors Correlations BRDU uptake histologic tumor type size Significant correlations BRDU uptake lymph node status patient age histologic tumor grade S-phase studies breast carcinomas techniques similar data Cell Proliferation Kit practical useful method vitro S-phase analysis concomitant histologic examination tumor tissue sample 